Gilead Sciences (GILD)

Gilead Sciences (GILD) Cash flow


Gilead Sciences Cash Flow

GILD's free cash flow for Q3 2023 was $2.35B. For the 2023 fiscal year, GILD's free cash flow was decreased by $-2.46B and operating cash flow was $2.47B. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ 8.40B$ 9.07B$ 11.38B$ 8.17B$ 9.14B$ 8.40B
Investing Cash Flow
$ -1.91B$ -2.47B$ -3.13B$ -14.62B$ -7.82B$ 14.36B
Financing Cash Flow
$ -5.58B$ -6.47B$ -8.88B$ 770.00M$ -7.63B$ -12.32B
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 21.78B$ 5.41B$ 5.34B$ 6.00B$ 11.63B$ 17.94B
Income Tax Paid Supplemental Data
--$ 2.51B$ 2.64B$ 1.79B$ 3.20B
Interest Paid Supplemental Data
--$ 979.00M$ 951.00M$ 982.00M$ 1.07B
Issuance Of Capital Stock
$ 382.00M-$ 169.00M$ 256.00M$ 209.00M$ 289.00M
Issuance Of Debt
$ -271.00M$ -1.50B$ -4.75B$ 8.18B$ 0.00$ 0.00
Repayment Of Debt
$ -2.25B$ -1.50B$ -4.75B$ -2.50B$ -2.75B$ -6.25B
Free Cash Flow
$ 7.85B$ 8.34B$ 10.80B$ 7.52B$ 8.32B$ 7.48B
Domestic Sales
Foreign Sales
Currency in USD

Gilead Sciences Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis